Ranjan Piyush, Bansal Rinkesh Kumar, Mehta N, Lalwani S, Kumaran V, Sachdeva M K, Kumar M, Nundy S
Department of Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110 060, India.
Department of Surgical Gastroenterology and Liver Transplantation, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110 060, India.
Indian J Gastroenterol. 2016 Jan;35(1):48-54. doi: 10.1007/s12664-016-0625-4. Epub 2016 Feb 13.
Liver transplantation has become common in India over the last decade and biliary strictures after the procedure cause a significant morbidity. Endoscopic retrograde cholangiopancreatography (ERCP) is a safe and effective treatment modality for post-transplant biliary strictures so we decided to evaluate prospectively the outcomes of endoscopic treatment in post-living donor liver transplantation (LDLT) biliary strictures.
We studied ten consecutive patients who had developed biliary strictures (out of 312 who had undergone liver transplantation between June 2009 and June 2013) and had been referred to the Department of Gastroenterology for management. All patients underwent liver function tests, ultrasound of the abdomen, magnetic resonance cholangiography and liver biopsy, if this was indicated.
Of these 312 patients who underwent liver transplantation, 305 had living donors (LDLT) and 7 deceased donors (DDLT). Ten patients in the LDLT group (3.3%) developed biliary strictures. There were seven males and three females who had median age of 52 years (range 4-60 years). The biliary anastomosis was duct-to-duct in all patients with one patient having an additional duct-to-jejunum anastomosis. The mode of presentation was cholangitis in four patients (40%), asymptomatic elevation of liver enzymes in four (40%) and jaundice in two patients (20%). The median time from transplantation to the detection of the stricture was 12 months (2-42.5 months). ERCP was attempted as initial therapy in all patients: seven were managed entirely by endoscopic therapy, and three required a combined percutaneous and endoscopic approach. Cholangiography demonstrated anastomotic stricture in all patients. A total of 32 sessions of ERCP were done with mean of 3.2 (2-5) endoscopic sessions and 3.4 (1-6) stents required to resolve the stricture. The median time from the first intervention to stricture resolution was 4 months (range 2-12 months). In four patients, the stents were removed after one session and in two patients each after two, three and four sessions. In six patients more than one stent was placed and all of them required dilatation of stricture. Seven patients completed treatment and are off stents at a median follow up period of 9.5 months (7-11 months). Two patients developed recurrence of their stricture after 7.5 months. Both had long strictures and required a combined endoscopic and percutaneous approach. There was one mortality due to sepsis secondary to cholangitis.
Post-LDLT biliary strictures can be successfully treated with ERCP, and most patients remain well on follow up (median 9.5 months). A combined endoscopic and percutaneous approach is useful when ERCP alone fails.
在过去十年中,肝移植在印度已变得很常见,术后胆管狭窄会导致显著的发病率。内镜逆行胰胆管造影术(ERCP)是治疗移植后胆管狭窄的一种安全有效的治疗方式,因此我们决定前瞻性地评估内镜治疗在活体供肝肝移植(LDLT)术后胆管狭窄中的疗效。
我们研究了连续10例发生胆管狭窄的患者(在2009年6月至2013年6月期间接受肝移植的312例患者中),这些患者被转诊至胃肠病科进行治疗。所有患者均进行了肝功能检查、腹部超声、磁共振胆胰管造影检查,必要时进行了肝活检。
在这312例接受肝移植的患者中,305例有活体供体(LDLT),7例有尸体供体(DDLT)。LDLT组中有10例患者(3.3%)发生了胆管狭窄。其中男性7例,女性3例,中位年龄为52岁(范围4 - 60岁)。所有患者的胆管吻合方式均为端端吻合,1例患者还进行了端侧空肠吻合。临床表现为胆管炎4例(40%)、肝酶无症状升高4例(40%)、黄疸2例(20%)。从移植到发现狭窄的中位时间为12个月(2 - 42.5个月)。所有患者均尝试将ERCP作为初始治疗:7例完全通过内镜治疗,3例需要经皮和内镜联合治疗。胆管造影显示所有患者均存在吻合口狭窄。共进行了32次ERCP,平均内镜治疗次数为3.2次(2 - 5次),解决狭窄所需的支架数量为3.4个(1 - 6个)。从首次干预到狭窄缓解的中位时间为4个月(范围2 - 12个月)。4例患者在1次治疗后取出支架,2例患者分别在2次、3次和4次治疗后取出支架。6例患者放置了不止一个支架,所有这些患者均需要对狭窄进行扩张。7例患者完成治疗,在中位随访期9.5个月(7 - 11个月)时已停用支架。2例患者在7.5个月后出现狭窄复发。这2例患者的狭窄均较长,需要内镜和经皮联合治疗。有1例患者因胆管炎继发败血症死亡。
LDLT术后胆管狭窄可以通过ERCP成功治疗,大多数患者在随访中情况良好(中位随访9.5个月)。当单独使用ERCP失败时,内镜和经皮联合治疗是有用的。